Narrow Therapeutic Index Drugs: Why Stricter Bioequivalence Rules Matter for Patient Safety
June 11, 2026
Alyssa Penford
0 Comments
Explore why Narrow Therapeutic Index (NTI) drugs require stricter bioequivalence standards. Learn how FDA and EMA regulations ensure generic safety for critical medications like warfarin and levothyroxine.
